|
|
||||||||
AJP - Regulatory, Integrative and Comparative Physiology, Vol 271, Issue 1 254-R261, Copyright © 1996 by American Physiological Society
ARTICLES |
M. Gellai, T. Fletcher, M. Pullen and P. Nambi
Department of Renal Pharmacology, SmithKline Beecham Pharmaceuticals, King of Prussia, Pennsylvania 19406-0939, USA.
The physiological roles of endothelin-B (ETB) receptor subtypes in systemic and renal hemodynamics were assessed in conscious Sprague-Dawley rats. Mean arterial pressure, hindlimb flow, and renal blood flow were measured via an implanted catheter and pulsed Doppler flow probes. Bolus intravenous injections of sarafotoxin 6c (S6c), a selective ETB agonist, elicited transient dose-dependent vasodilation, followed by sustained vasoconstriction in the systemic bed, but only vasoconstriction in the renal bed. RES-701-1, a selective ETB antagonist, blocked the dilator and potentiated the constrictor effect; SB-209670, a mixed ET receptor antagonist, attenuated both responses to S6c. In follow-up studies, the role of endogenous ET was assessed by administration of the antagonists alone: RES-701-1, SB-209670, and the ETA-selective antagonist BQ-123. RES-701-1 unmasked a significant systemic and renal vasoconstriction, which was attenuated by SB-209670 but not by BQ-123. SB-209670 and BQ-123 had no effect on basal hemodynamic parameters. Data from radioligand binding experiments showed that RES-701-1 binds with high affinity to the cloned human ETB receptor but poorly to the ETB receptor predominant in the rat kidney. Collectively, the results indicate that 1) the vascular effects of ET in the rat are mediated by two ETB receptor subtypes: an RES-701-1-sensitive subtype, mediating vasodilation, and an RES-701-1-insensitive subtype, mediating vasoconstriction; 2) the predominant role of endogenous ET is vasodilation; and 3) the ETA receptor plays a negligible role in the control of vascular tone in the rat.
This article has been cited by other articles:
![]() |
T. L. Thai and W. J. Arendshorst ADP-ribosyl cyclase and ryanodine receptors mediate endothelin ETA and ETB receptor-induced renal vasoconstriction in vivo Am J Physiol Renal Physiol, August 1, 2008; 295(2): F360 - F368. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Just, A. J. M. Olson, J. R. Falck, and W. J. Arendshorst NO and NO-independent mechanisms mediate ETB receptor buffering of ET-1-induced renal vasoconstriction in the rat Am J Physiol Regulatory Integrative Comp Physiol, May 1, 2005; 288(5): R1168 - R1177. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. P. Conrad and J. Novak Emerging role of relaxin in renal and cardiovascular function Am J Physiol Regulatory Integrative Comp Physiol, August 1, 2004; 287(2): R250 - R261. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Just, A. J. M. Olson, and W. J. Arendshorst Dual constrictor and dilator actions of ETB receptors in the rat renal microcirculation: interactions with ETA receptors Am J Physiol Renal Physiol, April 1, 2004; 286(4): F660 - F668. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. X. Li, M. Bek, L. D. Asico, Z. Yang, D. K. Grandy, D. S. Goldstein, M. Rubinstein, G. M. Eisner, and P. A. Jose Adrenergic and Endothelin B Receptor-Dependent Hypertension in Dopamine Receptor Type-2 Knockout Mice Hypertension, September 1, 2001; 38(3): 303 - 308. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. A. Danielson, L. J. Kercher, and K. P. Conrad Impact of gender and endothelin on renal vasodilation and hyperfiltration induced by relaxin in conscious rats Am J Physiol Regulatory Integrative Comp Physiol, October 1, 2000; 279(4): R1298 - R1304. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. G. Nussdorfer, G. P. Rossi, L. K. Malendowicz, and G. Mazzocchi Autocrine-Paracrine Endothelin System in the Physiology and Pathology of Steroid-Secreting Tissues Pharmacol. Rev., September 1, 1999; 51(3): 403 - 438. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. P. Conrad, R. E. Gandley, T. Ogawa, S. Nakanishi, and L. A. Danielson Endothelin mediates renal vasodilation and hyperfiltration during pregnancy in chronically instrumented conscious rats Am J Physiol Renal Physiol, May 1, 1999; 276(5): F767 - F776. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. H. Ohlstein, P. Nambi, D. W. P. Hay, M. Gellai, D. P. Brooks, J. Luengo, J.-N. Xiang, and J. D. Elliott Nonpeptide Endothelin Receptor Antagonists. XI. Pharmacological Characterization of SB 234551, a High-Affinity and Selective Nonpeptide ETA Receptor Antagonist J. Pharmacol. Exp. Ther., August 1, 1998; 286(2): 650 - 656. [Abstract] [Full Text] |
||||
![]() |
C. A. Kirton and R. Loutzenhiser Alterations in basal protein kinase C activity modulate renal afferent arteriolar myogenic reactivity Am J Physiol Heart Circ Physiol, August 1, 1998; 275(2): H467 - H475. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Mazzocchi, L. K. Malendowicz, F. G. Musajo, G. Gottardo, A. Markowska, and G. G. Nussdorfer Role of endothelins in regulation of vascular tone in the in situ perfused rat adrenals Am J Physiol Endocrinol Metab, January 1, 1998; 274(1): E1 - E5. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |